Asia-Pacific Gastroenterology Cancer Summit (APGCS) posted on LinkedIn:
“Explore the evolving landscape of targeted therapies in metastatic colorectal cancer with a focus on BRAF-mutant mCRC.
Join renowned experts:
- Dr. Chee Cheng Ean, National University Cancer Institute
- Dr. Jayesh Desai, Peter MacCallum Cancer Center
- Dr. Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori
As they lead a powerful discussion on: “Personalised Medicine in BRAF-mutant mCRC – Where Are We Now in 2025?”
Don’t miss this data-driven, practice-shaping symposium only at APGCS 2025.
More posts featuring APGCS.